April 28, 2020 / 12:37 PM / a month ago

BRIEF-Odonate Therapeutics Reports Quarterly Loss Per Share $0.99

April 28 (Reuters) - Odonate Therapeutics Inc:

* ODONATE THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2020

* QUARTERLY LOSS PER SHARE $0.99

* AS OF MARCH 31, 2020, ODONATE HAD $153.1 MILLION IN CASH, COMPARED TO $180.5 MILLION AS OF DECEMBER 31, 2019

* CONTINUE TO EXPECT TO REPORT TOP-LINE RESULTS FROM CONTESSA, AS A POTENTIAL TREATMENT FOR BREAST CANCER, IN Q3 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below